Rohto Pharmaceutical Co (TSE:4527) Construction In Progress: 円5,147 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4527 Rohto Pharmaceutical Co Ltd TSE:4527
92 GF Score
Price 円2,435.00
GF Value 円3,477.35
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Rohto Pharmaceutical Co Construction In Progress?

Rohto Pharmaceutical Co TSE:4527 -1.72% 92 Construction In Progress is 円5,147 Mil as of Mar. 2026. GuruFocus rates TSE:4527 with a GF Score™ of 92/100 and a GF Value™ of 円3,477.35 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Rohto Pharmaceutical Co's quarterly construction in progress stayed the same from Sep. 2025 (円0 Mil) to Dec. 2025 (円0 Mil) but then increased from Dec. 2025 (円0 Mil) to Mar. 2026 (円5,147 Mil).

Rohto Pharmaceutical Co's annual construction in progress increased from Mar. 2024 (円4,288 Mil) to Mar. 2025 (円4,344 Mil) and increased from Mar. 2025 (円4,344 Mil) to Mar. 2026 (円5,147 Mil).

Rohto Pharmaceutical Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Rohto Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rohto Pharmaceutical Co Construction In Progress Chart

Rohto Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,588.00 3,540.00 4,288.00 4,344.00 5,147.00

Rohto Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,344.00 0.00 0.00 0.00 5,147.00
TSE:4527
92GF Score
Rohto Pharmaceutical Co Ltd TSE:4527
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rohto Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of 円5,147 Mil mean?
Rohto Pharmaceutical Co (TSE:4527) has a Construction In Progress of 円5,147 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Rohto Pharmaceutical Co and its competitors.
Is Rohto Pharmaceutical Co's Construction In Progress too high?
Rohto Pharmaceutical Co's current Construction In Progress is 円5,147 Mil. Overall, Rohto Pharmaceutical Co has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rohto Pharmaceutical Co's Construction In Progress compare to PG and CL?
Rohto Pharmaceutical Co's Construction In Progress of 円5,147 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Consumer Packaged Goods company?
A good Construction In Progress depends on the Consumer Packaged Goods industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Rohto Pharmaceutical Co and its competitors. Rohto Pharmaceutical Co's current Construction In Progress is 円5,147 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rohto Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Rohto Pharmaceutical Co (TSE:4527) is currently considered Significantly Undervalued. The stock's GF Value™ is 円3,477.35, compared to a current price of 円2,435.00 — trading 30% below its estimated fair value. The current Construction In Progress is 円5,147 Mil. Rohto Pharmaceutical Co's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Rohto Pharmaceutical Co (TSE:4527), the current Construction In Progress is 円5,147 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rohto Pharmaceutical Co (TSE:4527) Overvalued in 2026?

Based on GuruFocus' analysis, Rohto Pharmaceutical Co stock appears to be undervalued. The current stock price of 円2,435.00 is trading 30% below its estimated GF Value™ of 円3,477.35. GuruFocus considers Rohto Pharmaceutical Co to be Significantly Undervalued.

Key valuation signals for TSE:4527:

  • Construction In Progress: 円5,147 Mil
  • GF Value™: 円3,477.35 vs. price of 円2,435.00 (30% below fair value)
  • GF Score™: 92/100 with 2 warning signs

No single metric tells the full story. See the TSE:4527 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rohto Pharmaceutical Co Business Description

Other Exchanges RPHCF:USAUC1:Germany
Address 1-8-1 Tatsuminishi, Ikuno-ku, Osaka, JPN, 544-8666
Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty care products. The company operates through four reportable segments: Japan, America, Europe, and Asia. Each segment manufactures and sells products related to eye care (such as eye drops and eyewash), skin care (including dermatological medications, lip balm, sunscreen, and functional cosmetics), oral medication (such as gastrointestinal and herbal medicines, and supplements), and other products such as in-vitro diagnostic reagents. It generates the majority of its revenue from Japan.
92GF Score

Get the complete analysis for TSE:4527

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,435.00
Price
円3,477.35
GF Value